Status: Recruiting
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors
Brief Summary: The purpose of this clinical trial is to evaluate the safety, tolerability, preliminary efficacy, and immunogenicity of EVM14 administered intramuscularly (IM) alone and in combination with pembrolizumab in patients with selected solid tumors.
Participants needed: 94
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Everest Medicines (Beijing) Co., Ltd.Updated: Aug 4, 2026Locations: 7
Eligibility criteria
Selected types of solid tumor that are pathologically confirmed unresectable adv... [+5]
Has disease that is suitable for local treatment administered with curative inte... [+12]